You are currently viewing Stereotactic Surgery Devices Market Explained: What Is Fueling Growth To $30.94 Billion By 2030?
Stereotactic Surgery Devices Market Analysis

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

#Stereotactic Surgery Devices Market Size Forecast: How Big Could The Market Get By 2030?#_x000D_

The stereotactic surgery devices market has demonstrated robust expansion recently. This market is projected to expand from $22.44 billion in 2025 to $23.84 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.2%. Factors contributing to its historical growth include an increase in neurological disorder cases, the proliferation of neurosurgical centers, greater adoption of gamma knife systems, the rise of minimally invasive brain procedures, and progress in medical imaging technologies._x000D_

_x000D_

The stereotactic surgery devices market is anticipated to show significant expansion over the next few years. It is projected to reach a value of $30.94 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.7%. This expected growth within the forecast period can be linked to a surging demand for precise neurosurgery, increased financial commitments to advanced radiosurgery platforms, the wider application of AI-assisted surgical planning, a growing preference for non-invasive treatment approaches, and a stronger focus on individualized patient care. Significant trends during this period are predicted to encompass the increasing adoption of image-guided stereotactic systems, the rising utilization of robotic-assisted neurosurgical platforms, deeper integration of high-precision navigation technologies, an expansion of non-invasive radiosurgery solutions, and an intensified focus on treatment accuracy and patient safety._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=88042008&type=smp&name=Stereotactic%20Surgery%20Devices%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Stereotactic Surgery Devices Market Development Factors: What’s Supporting Demand?#_x000D_

The increasing prevalence of Parkinson’s disease and epilepsy is anticipated to stimulate the expansion of the stereotactic surgical device market in the future. Parkinson’s disease is a neurodegenerative condition characterized by involuntary tremors, slow movement, and rigid, inflexible muscles, while epilepsy is a neurological condition impacting the brain, making patients more susceptible to experiencing repeated, unprovoked seizures. Stereotactic surgical devices are utilized in treating movement disorders, epilepsy, pain, and psychiatric conditions, including Parkinson’s disease. For instance, in November 2024, the British Psychological Society, a UK-based representative body for psychology, stated that approximately 100,000 individuals in Wales live with long-term neurological conditions. This includes over 41,000 affected by disorders such as Parkinson’s disease, epilepsy, multiple sclerosis, muscular dystrophy, motor neurone disease, and cerebral palsy, with around 2,500 new cases of Parkinson’s disease, epilepsy, multiple sclerosis, or motor neurone disease diagnosed each year. Consequently, the rising instances of Parkinson’s disease and epilepsy are propelling the growth of the stereotactic surgical device market._x000D_

_x000D_

#Stereotactic Surgery Devices Market Segment Trends And Revenue Contributors#_x000D_

The stereotactic surgery devices market covered in this report is segmented – _x000D_

_x000D_

1) By Product: Gamma Knife, Line Accelerator (LINAC) Machines, CyberKnife _x000D_

2) By Application: Brain Tumor Treatment, Arteriovenous Malformations Treatment, Parkinsons Disease, Epilepsy, Other Applications _x000D_

3) By End User: Hospitals, Specialty Neurosurgical Centers, Cancer Treatment Centers, Academic And Research Medical Centers_x000D_

_x000D_

Subsegments:_x000D_

1) By Gamma Knife: Leksell Gamma Knife Perfexion, Leksell Gamma Knife Icon_x000D_

2) By Line Accelerator (LINAC) Machines: Conventional LINAC, Image-Guided Radiation Therapy (IGRT) LINAC_x000D_

3) By CyberKnife: CyberKnife M6 System, CyberKnife VSI System_x000D_

_x000D_

#Stereotactic Surgery Devices Market Transformation Trends: What Innovations Are Driving Change?#_x000D_

Leading companies within the stereotactic surgical device market are prioritizing the creation of sophisticated tracking and positioning solutions to enhance procedural accuracy, ensure patient safety, and optimize therapeutic results. These innovations are designed to offer high-precision localization, continuous real-time observation, and increased operational effectiveness during stereotactic interventions, including radiosurgery and body radiation therapy. A notable example occurred in May 2023, when Brainlab, a Germany-based medical technology company, launched ExacTrac Dynamic Surface, a next-generation surface-guided radiation therapy (SGRT) patient tracking and positioning system. This solution integrates high-speed thermal surface tracking with enhanced ExacTrac X-ray monitoring, allowing for more versatile and precise patient alignment during cranial and spine stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). The system projects a structured blue light pattern onto the patient, captured by two 3D cameras, while an additional in-unit camera records thermal signatures, ensuring accurate registration of every surface point. This technological advancement supports more dependable and controlled delivery of stereotactic treatments._x000D_

_x000D_

#Stereotactic Surgery Devices Market Competitive Overview And Top Companies#_x000D_

Major companies operating in the stereotactic surgery devices market are Elekta AB, Varian Medical Systems Inc., Accuray Incorporated, Ion Beam Applications S.A., ZAP Surgical Systems Inc., Brainlab AG, Monteris Medical Holding AG, Renishaw plc, Medtronic plc, Nexstim Plc, FHC Inc., Alpha Omega Engineering Inc., Mitsubishi Heavy Industries Ltd., Inomed Medizintechnik GmbH, MRI Interventions Inc., Modus Medical Devices Inc., Scopis GmbH, Neuropace Inc., Adeor Medical AG, Huiheng Group Co Ltd _x000D_

_x000D_

#View The Full Stereotactic Surgery Devices Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/stereotactic-surgery-devices-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Stereotactic Surgery Devices Market Leading Geography: Which Region Contributes The Most Revenue?#_x000D_

North America was the largest region in the stereotactic surgery devices market in 2025. The regions covered in the stereotactic surgery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model